Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bellinger

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Occupational and Environmental Medicine|June 8, 2006
Delta-aminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging StudyJ Weuve, K T Kelsey, J Schwartz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogsM A Kay, C N Landen, S R Rothenberg, et al.
American Journal of Industrial Medicine|January 1, 1992
The goal: safety and equalityJ E Bertin, N A Ashford, D Bellinger, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Occupational and Environmental Medicine|June 8, 2006
Delta-aminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging StudyJ Weuve, K T Kelsey, J Schwartz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogsM A Kay, C N Landen, S R Rothenberg, et al.
American Journal of Industrial Medicine|January 1, 1992
The goal: safety and equalityJ E Bertin, N A Ashford, D Bellinger, et al.
Pageof 8